Buy
Average AnalystSell
Top AnalystSlightly Bearish
Stock Target AdvisorN/A
Average UserUSD 100.72
+0.48 (+0.48)%
N/A
0.18M
USD 86.75(-13.87%)
Symbol | Name | Exchange | CNS's Weight | Expense Ratio | Price(Change) | Market Cap |
---|---|---|---|---|---|---|
|
VanEck Bionic Engineering.. | XETRA | 4.45 % | 0.00 % | -0.13 (-0.67%) | USD4.90M |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
This stock has shown below median revenue growth in the previous 5 years compared to its sector
This stock has shown below median earnings growth in the previous 5 years compared to its sector